Complete Post-mortem Investigations in a Death Involving Clenbuterol After Long-term Abuse

Author:

Kintz Pascal12,Gheddar Laurie2,Ameline Alice2,Dumestre-Toulet Véronique3,Verschoore Marion4,Comte Julien4,Raul Jean-Sébastien2

Affiliation:

1. X-Pertise Consulting, 42 Rue Principale, F-67206 Mittelhausbergen, France

2. Institut de Médecine Légale, 11 Rue Humann, F-67000 Strasbourg, France

3. Laboratoire ToxGen, 11 Rue du Commandant Cousteau, F-33100 Bordeaux, France

4. Unité de Medicine Légale, Place Amélie Raba-Léon, F-33000 Bordeaux, France

Abstract

Abstract The body of a 61-year-old man was found at his home by his wife, lying on the floor, near the bathroom, around midnight. He was known to be training for bodybuilding, using anabolic steroids. Police investigations revealed the presence of two types of tablets at home, one supposed to contain clenbuterol (0.040 mg) and the other stanozolol (10 mg). Testing the tablets revealed different dosages from what was expected, i.e., 0.073 and 11.5 mg/tablet, for clenbuterol and stanozolol, respectively. External body examination and autopsy, which was performed the next day, revealed generalized organ congestion and lack of any traumatic injury (confirmed by radiology). Cardiomegaly, with a heart weighing 692 g, was obvious. Anatomic pathology tests did not reveal evidence of malformations, but atheromatous plaque was identified in the coronaries during complete histology investigations. Femoral blood, urine, bile, gastric contents and two strands of hair (6 cm) were collected for toxicology. These specimens were submitted to standard analyses, but also to a specific LC–MS-MS method for clenbuterol and stanozolol testing. Clenbuterol was identified in all the tissues, including femoral blood (1.1 ng/mL), urine (7.2 ng/mL), bile (2.4 ng/mL), gastric content (3.2 ng/mL) and hair (23 pg/mg). Stanozolol only tested positive in hair (11 pg/mg). All other analyses were negative, including blood alcohol and drugs of abuse. The pathologists concluded to cardiac insufficiency with support of cardiomegaly, in a context involving repetitive abuse of anabolic drugs. This case indicates that more attention should be paid to clenbuterol, a drug widely used as a stimulant by people who want to lose weight, athletes and bodybuilding practitioners.

Publisher

Oxford University Press (OUP)

Subject

Chemical Health and Safety,Health, Toxicology and Mutagenesis,Toxicology,Environmental Chemistry,Analytical Chemistry

Reference24 articles.

1. ß-2 agonists as misusing drugs? Assessment of both clenbuterol- and salbutamol-related European medicines agency pharmacovigilance database reports;Milano;Basic & Clinical Pharmacology & Toxicology,2018

2. Clenbuterol: a substitute for anabolic steroids;Prather;Medicine and Science in Sports and Exercice,1995

3. Detection of clenbuterol in heroin users in twelve post-mortem cases at the Philadelphia medical examiner’s office;Wingert;Journal of Analytical Toxicology,2008

4. Food poisoning by clenbuterol in Portugal;Barbosa;Food Additives & Contaminants,2005

5. Myocrdial ischemia associated with clenbuterol abuse: report of two cases;Huckins;The Journal of Emergency Medicine,2013

Cited by 22 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3